A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01037036
Recruitment Status : Completed
First Posted : December 21, 2009
Last Update Posted : January 10, 2014
QLT Inc.
Information provided by (Responsible Party):
Mati Therapeutics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2010
  Actual Study Completion Date : July 2010
  Certification/Extension First Submitted : June 17, 2011